#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Essential thrombocythaemia Hepatitis D Anti-HLA antibody test positive Polycythaemia vera Fallopian tube cancer Dermatitis Acute graft versus host disease in skin Microvillous inclusion disease Cholangiocarcinoma Stress cardiomyopathy Stargardt's disease Atypical haemolytic uraemic syndrome Congenital disorder of glycosylation Vitamin B12 deficiency Congenital cystic kidney disease More trials…

    Learn about Rare Diseases

    Mantle cell lymphoma refractory – Basic Information Pleomorphic leiomyosarcoma Hereditary hypophosphataemic rickets – Diagnostics Acute respiratory distress syndrome – Trials in Disease Urea cycle disorder – Life with Disease Idiopathic pulmonary fibrosis – Life with Disease Marginal zone lymphoma – Diagnostics Castleman’s disease – Trials in Disease Skin angiosarcoma Cystic fibrosis – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Evencaleucel Lsta1 Ivonescimab Calcifediol Dog Epithelia Pramlintide Acetate ARI0008 Dersimelagon Phosphate Pembrolizumab Mitomycin Amikacin ACT-1004-1239 VISUGROMAB Msv/As Litifilimab Histidine Levofloxacin Envudeucitinib Bi 3720931 Afatinib More therapies…

    Learn about Your Condition

    Pyoderma gangrenosum Metastatic gastric cancer Nephrolithiasis Progressive supranuclear palsy Cutaneous lupus erythematosus Skin wrinkling Rectal cancer Neonatal asphyxia Small cell carcinoma Delayed graft function Trigeminal neuralgia Paget's disease of the vulva Gastrointestinal carcinoma Breast cancer stage II Cervix carcinoma recurrent More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • Study on the Safety and Effects of YTB323 and Drug Combination for Patients with Treatment-Resistant Generalized Myasthenia Gravis

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • Myasthenia gravis
    Investigated Drugs:
    • Fludarabine Phosphate
    • Human Normal Immunoglobulin (Iv)
    • Rapcabtagene Autoleucel
    France

  • Study on the Safety of Self-Infusion Therapy with Human Alpha1-Proteinase Inhibitor for Patients with Severe Alpha-1 Antitrypsin Deficiency

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Human Alpha1-Proteinase Inhibitor
    Germany

  • Study of Ketamine Alone and Ketamine-Propofol Combination Compared to Propofol for Rapid Sequence Induction in Operating Room Patients at Risk of Aspiration

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Ketamine
    • Propofol
    France

  • Study on the Safety and Effectiveness of Eltanexor for Patients with Relapsed or Refractory NPM1-Mutated Acute Myeloid Leukemia

    Recruiting

    2 1 1
    Investigated Diseases:
    • Acute myeloid leukaemia recurrent
    • Acute myeloid leukaemia refractory
    Investigated Drugs:
    • ELTANEXOR
    Italy

  • Study of atropine eye drops (0.

    Recruiting

    3 1
    Investigated Diseases:
    • Myopia
    Investigated Drugs:
    • Atropine Sulfate Monohydrate
    Italy Poland Spain

  • Study on Low-Dose Gadolinium for Breast Cancer MRI in Patients Using Gadoteric Acid

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Breast cancer
    Investigated Drugs:
    • Gadoteric Acid
    The Netherlands
Previous Page
1 … 282 283 284 285 286 … 1,650
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!